Skip to main content

Table 2 Relationship of serum fibrosis biomarkers with demographic T1 mapping data

From: Extracellular volume(ECV) quantified by T1 mapping could reflect effect of long term blood pressure control status in patients with essential hypertension

 

PICP

   

ICTP

 

PICP/ICTP

   
 

r

P value

β

P value

r

P value

r

P value

β

P value

Age, yrs

0.20

0.11

  

0.14

0.26

0.10

0.44

  

BMI, kg/m2

0.01

0.94

  

0.14

0.29

0.23

0.07

  

SBP, mmHg

0.15

0.25

  

0.18

0.16

0.25*

0.04

-0.19

0.32

DBP, mmHg

0.28*

0.03

0.11

0.46

0.17

0.18

0.27*

0.03

0.36

0.06

LVEF, %

0.20

0.12

  

0.16

0.23

-0.16

0.20

  

LV mass, g

0.18

0.15

  

0.28*

0.03

-0.07

0.68

  

IVS, mm

0.27*

0.03

-0.05

0.78

0.04

0.80

0.24

0.06

  

Native T1 time, msec

0.16

0.21

  

0.01

0.92

0.16

0.20

  

Post-contrast T1 time, msec

0.05

0.67

  

-0.08

0.53

0.10

0.42

  

ECV, %

0.4*

0.01

0.37*

0.02

0.07

0.60

0.37*

0.003

0.30*

0.03

  1. Values are mean ± SD.
  2. PICP: carboxy-terminal propeptide of procollagen type I; ICTP: carboxy-terminal telopeptide of collagen type I; BMI = body mass index; SBP = systolic blood pressure, DBP = diastolic blood pressure; LVEF = left ventricular ejection fraction; IVS = interventricular septum; ECV = extracellular volume fraction.
  3. * p <0.05.